Lauren Gardner

1 day ago | politico.com | Lauren Gardner |Kelly Hooper |Chelsea Cirruzzo

With Robert King and Ben Leonard House E&C Chair Brett Guthrie, left, and ranking member Frank Pallone were in a marathon committee markup meeting where much of the talk centered around Medicaid cuts. | Anna Moneymaker/Getty Images LONG DAY’S JOURNEY — The Energy and Commerce Committee pulled an all-nighter debating the potential impacts of Republican proposals to change Medicaid, part of the GOP’s domestic policy megabill, Ben and Robert report.

1 week ago | politico.com | Lauren Gardner |David Lim

President Donald Trump seeks a most favored nation policy for drugs under Medicaid. | Mike Stewart/AP Photo A ‘MOST FAVORED’ APPROACH — A Trump 1.0-era drug-pricing specter is lurking around Republicans’ efforts to pass a party-line bill to pay for the president’s domestic agenda. The administration sought proposals this week on a “most favored nation” policy to cut prescription drug costs by linking certain government payments for medications to the lower prices paid overseas.

2 weeks ago | politico.com | Chelsea Cirruzzo |Lauren Gardner

“America has a big problem, and we have to face up to it,” said one of them, Jill Escher, president of the National Council on Severe Autism. The divide shows how Kennedy’s search for autism’s source — he’s pledged to have some answers by September — has inflamed a long-simmering debate among people who advocate for those with the neurodevelopmental disorder and suggests that his investigation, whatever its findings, will be politically explosive.

2 weeks ago | autism.einnews.com | Chelsea Cirruzzo |Lauren Gardner

“America has a big problem, and we have to face up to it,” said one of them, Jill Escher, president of the National Council on Severe Autism. The divide shows how Kennedy’s search for autism’s source — he’s pledged to have some answers by September — has inflamed a long-simmering debate among people who advocate for those with the neurodevelopmental disorder and suggests that his investigation, whatever its findings, will be politically explosive.

2 weeks ago | politico.com | Lauren Gardner |David Lim

With Chelsea Cirruzzo President Donald Trump's HHS overhaul over the past 100 days has some in the health industry concerned. | Kevin Dietsch/Getty Images 100 DAYS AND COUNTING — The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he strikes at the heart of medicine’s regulatory regime while raising questions about where he and Secretary Robert F. Kennedy Jr. plan to act next.